- Home
- NINE vs BOLD Comparison
NINE vs BOLD Comparison
Compare NINE & BOLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NINE
- BOLD
- Stock Information
- Founded
- NINE 2011
- BOLD 2018
- Country
- NINE United States
- BOLD United States
- Employees
- NINE N/A
- BOLD N/A
- Industry
- NINE Oilfield Services/Equipment
- BOLD
- Sector
- NINE Energy
- BOLD
- Exchange
- NINE Nasdaq
- BOLD Nasdaq
- Market Cap
- NINE 23.8M
- BOLD 24.4M
- IPO Year
- NINE 2018
- BOLD 2024
- Fundamental
- Price
- NINE $0.88
- BOLD $1.17
- Analyst Decision
- NINE
- BOLD Buy
- Analyst Count
- NINE 0
- BOLD 3
- Target Price
- NINE N/A
- BOLD $4.00
- AVG Volume (30 Days)
- NINE 8.9M
- BOLD 286.6K
- Earning Date
- NINE 08-05-2025
- BOLD 08-11-2025
- Dividend Yield
- NINE N/A
- BOLD N/A
- EPS Growth
- NINE N/A
- BOLD N/A
- EPS
- NINE N/A
- BOLD N/A
- Revenue
- NINE $562,450,000.00
- BOLD N/A
- Revenue This Year
- NINE $3.64
- BOLD N/A
- Revenue Next Year
- NINE N/A
- BOLD N/A
- P/E Ratio
- NINE N/A
- BOLD N/A
- Revenue Growth
- NINE N/A
- BOLD N/A
- 52 Week Low
- NINE $0.44
- BOLD $1.00
- 52 Week High
- NINE $2.02
- BOLD $4.72
- Technical
- Relative Strength Index (RSI)
- NINE 54.98
- BOLD N/A
- Support Level
- NINE $0.85
- BOLD N/A
- Resistance Level
- NINE $1.05
- BOLD N/A
- Average True Range (ATR)
- NINE 0.14
- BOLD 0.00
- MACD
- NINE 0.00
- BOLD 0.00
- Stochastic Oscillator
- NINE 21.80
- BOLD 0.00
About NINE Nine Energy Service Inc.
Nine Energy Service Inc is a North American onshore completion and production services provider. It targets unconventional oil and gas resource development. It operates in one segment, Completion Solutions. The Completion Solutions segment offers cementing services; completion tools, including liner hangers and accessories, frac sleeves, fully composite frac plugs, and specialty open hole float equipment and centralizers and other services. It operates in the U.S, Canada, and other countries where majority of the revenue is generated from the United States.
About BOLD Boundless Bio Inc. Common Stock
Boundless Bio Inc is a clinical-stage oncology company. The company is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.